Physician profile
Hannah Wade
NPI 1033893094
$2,450.10
in general payments reported to CMS, 2019-2025
9 companies · $1,674 in 2025
The $1,674 reported for 2025 was more than what 93% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $776 · 2025: $1,674.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,450.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,450.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Madrigal Pharmaceuticals | $1,021.90 | 2024-2025 | Rezdiffra, Resmetirom |
| Gilead Sciences, INC. | $504.62 | 2024-2025 | Livdelzi |
| Ipsen Biopharmaceuticals, INC | $457.98 | 2024-2025 | Iqirvo, Bylvay |
| Mirum Pharmaceuticals, INC. | $163.36 | 2024 | Livmarli |
| Intercept Pharmaceuticals, INC. | $124.36 | 2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $84.75 | 2024-2025 | Xifaxan |
| Novo Nordisk INC | $44.36 | 2025 | Wegovy |
| Vertex Pharmaceuticals Incorporated | $32.82 | 2025 | |
| Orphalan INC | $15.95 | 2024 | Cuvrior |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hannah Wade listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.